Tagged With "treatment"

Blog Post

FDA Approves Cinqair to Treat Severe Asthma

AAFA Community Services ·
FDA News Release FDA approves Cinqair to treat severe asthma For Immediate Release March 23, 2016 Inquiries Media Andrea Fischer 301-796-0393 Consumers 888-INFO-FDA Release The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current...
Blog Post

Xolair Approved for Children with Asthma Triggered by Allergens

AAFA Community Services ·
There is a new drug available for children with uncontrolled asthma caused by airborne allergens. Xolair is already approved for people, ages 12 and older, with moderate to severe asthma. It belongs to a class of drugs called biologics. It is given in a doctor’s office by injection. The FDA recently approved it for children between ages 6 and 11 whose asthma is not controlled with other long-term medications . Approval makes Xolair the only biologic for children with uncontrolled allergic...
Blog Post

FDA Approves Symbicort to Treat Asthma In Children Ages 6-12

AAFA Community Services ·
AstraZeneca announced that the US Food and Drug Administration (FDA) approved SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol 80/4.5 micrograms for the treatment of asthma in pediatric patients aged six up to 12 years.
Blog Post

FDA Approves Two New Asthma Inhalers

AAFA Community Services ·
[Press Release] Teva Announces FDA Approval of Two New RespiClick® Maintenance Inhalers for the Treatment of Asthma Approvals Expand Portfolio of Respiratory Medicines Delivered in RespiClick® Inhaler Designed to Eliminate the Need for Hand-Breath Coordination During Inhalation JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced that the U.S. Food and Drug Administration (FDA) approved two products for adolescent and adult patients with asthma.
Blog Post

Teva Announces FDA Approval of QVAR® RediHaler™ Inhaler

AAFA Community Services ·
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved QVAR® RediHaler™ (beclomethasone dipropionate HFA) inhalation aerosol, a breath-actuated inhaler for the maintenance treatment of asthma as a prophylactic therapy in patients 4 years of age and older.
Blog Post

FDA Approves New Flu Treatment

AAFA Community Services ·
Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.
Blog Post

How Do You Treat Your Eczema?

AAFA Community Services ·
There are a variety of treatments for eczema, including creams and ointments. But your doctor may also recommend moisturizing methods, like "soak and seal" and "wet wrapping." These therapies can help your topical medicines be more effective. Everyone's eczema is different, and there are many ways you can manage flare-ups. Talk to your doctor about therapies that may work best for you.
Blog Post

What Is a Biologic?

AAFA Community Services ·
Biologics are targeted therapies made from living organisms or natural sources. Biologic therapy involves injections every few weeks or so that are tailored to the individual. Biologics help normalize your immune system by controlling immune responses that lead to inflammation. There are biologic treatments available for people with moderate-to-severe asthma or atopic dermatitis (eczema).
Blog Post

AAFA Elevates Patient Voice in ICER Review of New Peanut Allergy Treatments

AAFA Community Services ·
On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — as well as non-commercialized oral immunotherapy (OIT).
Blog Post Featured

Asthma and Allergy Foundation of America Responds to Premature ICER Review of New Peanut Allergy Treatments

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access to new treatments for peanut allergy.
Blog Post

Living Life to Its Fullest One Year After Bronchial Thermoplasty

AAFA Community Services ·
Lexi Larabee, who has severe asthma, had bronchial thermoplasty one year ago and shared her experience with the Asthma and Allergy Foundation of America (AAFA). Below, Lexi tells us what her life has been like after the procedure.
Comment

Re: Living Life to Its Fullest One Year After Bronchial Thermoplasty

Melissa G ·
I absolutely love this!! So happy for you Lexi! What an inspiration you are to so many.
Comment

Re: Xolair Approved for Children with Asthma Triggered by Allergens

Jen ·
@JadesJourney How are things going with the Xolair?
Comment

Re: Xolair Approved for Children with Asthma Triggered by Allergens

Sgp8136 ·
Thank you for sharing your experience. My 10 year old is going to be starting Xolair very soon, we finally got the approval from our insurance. I’m hoping this is just what she needs. She has been hospitalized so many times and is constantly absent from school because of her asthma not to mention all the steroids she’s taken. We’ve tried so many different preventative medications and it just isn’t enough. I hope all goes well and there aren’t any side effects the possibility of that is...
Comment

Re: Xolair Approved for Children with Asthma Triggered by Allergens

K8sMom2002 ·
Welcome, SGP8136! I am hoping that your daughter will do well on the Xolair and will see improvements! Please know that you guys aren't alone as you go along ... you'll find plenty of support on AAFA's Asthma Support Community .
Comment

Re: Xolair Approved for Children with Asthma Triggered by Allergens

JadesJourney ·
Jade just started her first round of Xolair Injections this past week. She's SO brave! But...I have to admit...It was a bittersweet moment; watching her sit there, calm, asking the nurse to count slowly for her, watching the needle, as she was given both injections. Outside of respectfully saying that it "kind of hurt, a lot", she didn't complain, or cry, or move, or refuse, or scream...she just sat still and watched! As a mom, this was a like a dream come true...at first. [{Sidebar} At this...
Comment

Re: Xolair Approved for Children with Asthma Triggered by Allergens

Jen ·
@JadesJourney That is great that Jade is so brave during those shots. We have other members who have been on xolair as well and have discussed their experiences on our support forums.
Comment

Re: Xolair Approved for Children with Asthma Triggered by Allergens

K8sMom2002 ·
I totally get what you're saying here, @JadesJourney ... fingers crossed that these shots will give her some control over her asthma that has been lacking! WTG on you helping guide her so that she CAN ask those "big girl" questions about the medications she's on. Hang tight, Mama!
×
×
×
×